期刊
NATURE METHODS
卷 16, 期 3, 页码 239-+出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/s41592-019-0323-0
关键词
-
资金
- Burroughs Wellcome Fund [1013926]
- National Institutes of Health [R01HG009285, RO1CA222826, RO1GM123313, F32DK112682]
We present in vivo sequence-specific RNA base editing via adenosine deaminases acting on RNA (ADAR) enzymes with associated ADAR guide RNAs (adRNAs). To achieve this, we systematically engineered adRNAs to harness ADARs, and comprehensively evaluated the specificity and activity of the toolsets in vitro and in vivo via two mouse models of human disease. We anticipate that this platform will enable tunable and reversible engineering of cellular RNAs for diverse applications.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据